IFNG and cancer: Immune subtype expression analysis revealed that, across pan-cancer, the C1 subtype (Wound Healing) and C2 subtype (IFN-γ Dominant) are predominant in the TMED9 high-expression group, a result confirmed across several specific cancer types (Figure 3B, Supplementary Figure 4A).